1. Home
  2. HAE vs CENTA Comparison

HAE vs CENTA Comparison

Compare HAE & CENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HAE
  • CENTA
  • Stock Information
  • Founded
  • HAE 1971
  • CENTA 1955
  • Country
  • HAE United States
  • CENTA United States
  • Employees
  • HAE N/A
  • CENTA 6450
  • Industry
  • HAE Medical/Dental Instruments
  • CENTA Consumer Specialties
  • Sector
  • HAE Health Care
  • CENTA Consumer Discretionary
  • Exchange
  • HAE Nasdaq
  • CENTA Nasdaq
  • Market Cap
  • HAE 2.4B
  • CENTA 1.8B
  • IPO Year
  • HAE 1991
  • CENTA 1993
  • Fundamental
  • Price
  • HAE $51.31
  • CENTA $28.70
  • Analyst Decision
  • HAE Buy
  • CENTA Buy
  • Analyst Count
  • HAE 8
  • CENTA 4
  • Target Price
  • HAE $76.88
  • CENTA $36.67
  • AVG Volume (30 Days)
  • HAE 711.7K
  • CENTA 291.1K
  • Earning Date
  • HAE 11-06-2025
  • CENTA 11-24-2025
  • Dividend Yield
  • HAE N/A
  • CENTA N/A
  • EPS Growth
  • HAE 46.89
  • CENTA N/A
  • EPS
  • HAE 3.28
  • CENTA 2.14
  • Revenue
  • HAE $1,346,046,000.00
  • CENTA $3,120,375,000.00
  • Revenue This Year
  • HAE N/A
  • CENTA N/A
  • Revenue Next Year
  • HAE $6.42
  • CENTA $0.16
  • P/E Ratio
  • HAE $15.66
  • CENTA $13.31
  • Revenue Growth
  • HAE 0.91
  • CENTA N/A
  • 52 Week Low
  • HAE $47.32
  • CENTA $25.97
  • 52 Week High
  • HAE $94.99
  • CENTA $37.35
  • Technical
  • Relative Strength Index (RSI)
  • HAE 51.54
  • CENTA 47.95
  • Support Level
  • HAE $48.55
  • CENTA $27.83
  • Resistance Level
  • HAE $51.89
  • CENTA $29.74
  • Average True Range (ATR)
  • HAE 1.43
  • CENTA 0.68
  • MACD
  • HAE 0.56
  • CENTA 0.30
  • Stochastic Oscillator
  • HAE 85.48
  • CENTA 88.93

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

About CENTA Central Garden & Pet Company Nonvoting

Central Garden & Pet Co understands that home is central to life and has nurtured happy and healthy homes for over forty years. The segments of the company are the pet segment and garden segment. The company's trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a portfolio of more than sixty-five brands including Pennington, Nylabone, Kaytee, Amdro, and Aqueon, manufacturing and distribution capabilities, and a passionate, entrepreneurial growth culture. Central Garden and Pet is based in Walnut Creek, California, and has offices across North America and Europe.

Share on Social Networks: